<DOC>
	<DOCNO>NCT00092079</DOCNO>
	<brief_summary>The purpose study test safety , tolerability , effectiveness investigational drug dietary supplement reduce risk vitamin D insufficiency deficiency treatment osteoporosis men postmenopausal woman .</brief_summary>
	<brief_title>A Study MK0217A Dietary Supplement Men Postmenopausal Women With Osteoporosis ( 0217A-227 )</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Men postmenopausal woman osteoporotic Vitamin D deficiency Other disease bone mineral metabolism Digestive disease cause malabsorption Other medical condition adequately treat</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>